INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,162,256 | +48.0% | 36,757 | +90.9% | 0.00% | – |
| Q2 2023 | $785,300 | +8.0% | 19,257 | -1.3% | 0.00% | – |
| Q1 2023 | $726,802 | +12.4% | 19,501 | +5.2% | 0.00% | – |
| Q4 2022 | $646,651 | -44.9% | 18,534 | -11.5% | 0.00% | -100.0% |
| Q3 2022 | $1,173,000 | +6.2% | 20,954 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $1,104,000 | -29.5% | 21,320 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $1,566,000 | -47.5% | 21,556 | -14.6% | 0.00% | 0.0% |
| Q4 2021 | $2,983,000 | +0.8% | 25,232 | +14.4% | 0.00% | -50.0% |
| Q3 2021 | $2,958,000 | -14.2% | 22,051 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $3,446,000 | +89.7% | 21,282 | -6.0% | 0.00% | +100.0% |
| Q1 2021 | $1,817,000 | +116.6% | 22,641 | +46.8% | 0.00% | 0.0% |
| Q4 2020 | $839,000 | – | 15,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |